GlassScriptPhysician profile
Anshu Bhalla
NPI 1366502163
$679.60
in general payments reported to CMS, 2019-2025
14 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Geriatric Medicine (Family Medicine) provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.02 · 2020: $42.48 · 2021: $28.67 · 2022: $161 · 2023: $13.87 · 2024: $93.86 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $373.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $247.01 | 2024-2025 | Zepbound, Mounjaro |
| Currax Pharmaceuticals LLC | $107.00 | 2022-2023 | Contrave |
| Vivus LLC | $78.61 | 2024 | Qsymia |
| Novo Nordisk INC | $48.05 | 2021-2025 | Wegovy |
| Glaxosmithkline, LLC. | $42.51 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $27.38 | 2019 | |
| Novartis Pharmaceuticals Corporation | $22.96 | 2022 | |
| Electromed, INC. | $21.99 | 2019 | |
| Merck Sharp & Dohme LLC | $15.02 | 2022 | |
| Amgen INC. | $15.00 | 2022 | |
| Harmony Biosciences LLC | $14.95 | 2020 | |
| Edwards Lifesciences Corporation | $14.47 | 2022 | |
| Sanofi Pasteur INC. | $13.31 | 2019 | |
| Sunovion Pharmaceuticals INC. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anshu Bhalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.